ArticleCureus2026

Real-World Prescribing Patterns and Clinical Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Empagliflozin-Sitagliptin-Metformin Fixed-Dose Combination Therapy.

Balaji T Naik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.